$MXL
MAXLINEAR, INC Stock $mxl

$mxl Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000144530513001002 Filed on May 01, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$26.53M	$20.68M
YoY Change	28.29%	22.33%
Cost Of Revenue	$9.822M	$8.267M
YoY Change	18.81%	35.52%
Gross Profit	$16.71M	$12.35M
YoY Change	35.29%	14.05%
Gross Profit Margin	62.98%	59.73%
Selling, General & Admin	$7.403M	$6.959M
YoY Change	6.38%	44.98%
% of Gross Profit	44.3%	56.33%
Research & Development	$11.51M	$11.91M
YoY Change	-3.33%	50.73%
% of Gross Profit	68.88%	96.4%
Depreciation & Amortization	$981.0K	$870.0K
YoY Change	12.76%	24.29%
% of Gross Profit	5.87%	7.04%
Operating Expenses	$18.91M	$18.87M
YoY Change	0.25%	48.56%
Operating Profit	-$2.202M	-$6.451M
YoY Change	-65.87%	245.16%
Interest Expense	$4.000K	$19.00K
YoY Change	-78.95%	-81.0%
% of Operating Profit
Other Income/Expense, Net	-$73.00K	-$96.00K
YoY Change	-23.96%	-4.0%
Pretax Income	-$2.220M	-$6.501M
YoY Change	-65.85%	261.17%
Income Tax	$80.00K	$61.00K
% Of Pretax Income
Net Earnings	-$2.300M	-$6.562M
YoY Change	-64.95%	471.6%
Net Earnings / Revenue	-8.67%	-31.73%
Basic Earnings Per Share	-$0.07	-$0.20
Diluted Earnings Per Share	-$0.07	-$0.20
COMMON SHARES
Basic Shares Outstanding	32.82M shares	33.31M shares
Diluted Shares Outstanding	32.82M shares	33.31M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$58.90M	$76.10M
YoY Change	-22.6%	-17.1%
Cash & Equivalents	$17.17M	$23.80M
Short-Term Investments	$41.70M	$52.30M
Other Short-Term Assets	$1.400M	$1.200M
YoY Change	16.67%	-68.42%
Inventory	$8.662M	$6.800M
Prepaid Expenses
Receivables	$18.02M	$11.10M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$86.95M	$95.10M
YoY Change	-8.57%	-12.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.550M	$5.100M
YoY Change	28.43%	2.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$18.40M	$7.300M
YoY Change	152.05%
Other Assets	$264.0K	$200.0K
YoY Change	32.0%	-95.92%
Total Long-Term Assets	$25.29M	$13.40M
YoY Change	88.75%	24.07%
TOTAL ASSETS
Total Short-Term Assets	$86.95M	$95.10M
Total Long-Term Assets	$25.29M	$13.40M
Total Assets	$112.2M	$108.5M
YoY Change	3.45%	-8.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.798M	$3.500M
YoY Change	8.51%	-5.41%
Accrued Expenses	$4.924M	$13.30M
YoY Change	-62.98%	171.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$30.73M	$19.30M
YoY Change	59.21%	46.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$828.0K	$500.0K
YoY Change	65.6%	150.0%
Total Long-Term Liabilities	$828.0K	$500.0K
YoY Change	65.6%	150.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.73M	$19.30M
Total Long-Term Liabilities	$828.0K	$500.0K
Total Liabilities	$31.56M	$19.80M
YoY Change	59.37%	46.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.32M
YoY Change
Common Stock	$142.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$80.69M	$88.80M
YoY Change
Total Liabilities & Shareholders Equity	$112.2M	$108.5M
YoY Change	3.45%	-8.98%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$2.300M	-$6.562M
YoY Change	-64.95%	471.6%
Depreciation, Depletion And Amortization	$981.0K	$870.0K
YoY Change	12.76%	24.29%
Cash From Operating Activities	$801.0K	-$1.080M
YoY Change	-174.17%	-48.57%
INVESTING ACTIVITIES
Capital Expenditures	$542.0K	$848.0K
YoY Change	-36.08%	-221.14%
Acquisitions
YoY Change
Other Investing Activities	-$4.900M	-$2.100M
YoY Change	133.33%	-115.11%
Cash From Investing Activities	-$5.414M	-$3.183M
YoY Change	70.09%	-123.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$23.00K	$79.00K
YoY Change	-70.89%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$26.00K	$31.00K
YoY Change	-183.87%	-92.25%
NET CHANGE
Cash From Operating Activities	$801.0K	-$1.080M
Cash From Investing Activities	-$5.414M	-$3.183M
Cash From Financing Activities	-$26.00K	$31.00K
Net Change In Cash	-$4.639M	-$4.232M
YoY Change	9.62%	-136.48%
FREE CASH FLOW
Cash From Operating Activities	$801.0K	-$1.080M
Capital Expenditures	$542.0K	$848.0K
Free Cash Flow	$259.0K	-$1.928M
YoY Change	-113.43%	37.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-223000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5023000	USD
CY2013Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4924000	USD
CY2013Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	549000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	386000	USD
CY2012Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2223000	USD
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5527000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4510000	shares
CY2013Q1	us-gaap	Assets Assets	112245000	USD
CY2012Q4	us-gaap	Assets Assets	110597000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	98018000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7372000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3798000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14558000	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18019000	USD
CY2012Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-249000	USD
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9053000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8299000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	35000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	28000	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	141973000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	139210000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2789000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	86952000	USD
CY2013Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	60118000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	60084000	USD
CY2013Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	24900000	USD
CY2012Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	50265000	USD
CY2013Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	41727000	USD
CY2013Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	60111000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	60089000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	16000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	4000	USD
CY2013Q1	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions	16	debt_security
CY2013Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	18356000	USD
CY2012Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	5181000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	9000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	9000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21810000	USD
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2307000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6543000	USD
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17174000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23796000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28026000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4636000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4230000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	9822000	USD
CY2012Q1	us-gaap	Cost Of Revenue CostOfRevenue	8267000	USD
CY2012Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	1469000	USD
CY2013Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	2026000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	215000	USD
CY2013Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	201000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	981000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	870000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	275000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	16712000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	12416000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	3000	USD
CY2012Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6501000	USD
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9281000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7004000	USD
CY2013Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2220000	USD
CY2013Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	123000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	123000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	959000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3713000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3461000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	648000	USD
CY2013Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2277000	USD
CY2012Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1567000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1229000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1316000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-363000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	39000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-117000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-228000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	4000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	19000	USD
CY2013Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6224000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6658000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	8662000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	9891000	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3233000	USD
CY2013Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2438000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	59000	USD
CY2012Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	65000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	110597000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112245000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29568000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	30728000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-6562000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5414000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3183000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1080000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	801000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-2300000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	18867000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	18914000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2202000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6451000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1055000	USD
CY2013Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	738000	USD
CY2012Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	69000	USD
CY2013Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	64000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	264000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	257000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	19000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-12000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	7000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	796000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	828000	USD
CY2012Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-96000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-73000	USD
CY2013Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	627000	USD
CY2012Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	581000	USD
CY2012Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	24000	USD
CY2013Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	48000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	32172000	USD
CY2012Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	32390000	USD
CY2013Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2012Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	195000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	848000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	542000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	79000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	27300000	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	30250000	USD
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1494000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1370000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15165000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15603000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6550000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6866000	USD
CY2013Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1000	USD
CY2012Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	24000	USD
CY2012Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	11908000	USD
CY2013Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	11511000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61315000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59015000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	20683000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	26534000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	80689000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	80233000	USD
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33312000	shares
CY2013Q1	mxl	Accrued Litigation Fees Current AccruedLitigationFeesCurrent	637000	USD
CY2013Q1	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	9788000	USD
CY2012Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	7880000	USD
CY2013Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2013Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	50000	USD
CY2012Q4	mxl	Accrued Litigation Fees Current AccruedLitigationFeesCurrent	586000	USD
CY2013Q1	mxl	Accrued Technology License Payments Current AccruedTechnologyLicensePaymentsCurrent	3000000	USD
CY2012Q4	mxl	Accrued Technology License Payments Current AccruedTechnologyLicensePaymentsCurrent	2996000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7403000	USD
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6959000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2789000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2223000	USD
CY2013Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the unaudited consolidated financial statements. Actual results could differ from those estimates.</font></div></div>
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33312000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32821000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32821000	shares
CY2012Q4	mxl	Deferred Revenue And Deferred Profit DeferredRevenueAndDeferredProfit	2289000	USD
CY2013Q1	mxl	Deferred Revenue And Deferred Profit DeferredRevenueAndDeferredProfit	2937000	USD
CY2013Q1	mxl	Deferred Revenue And Deferred Profits DeferredRevenueAndDeferredProfits	648000	USD
CY2012Q1	mxl	Deferred Revenue And Deferred Profits DeferredRevenueAndDeferredProfits	-1515000	USD
CY2012Q4	mxl	Deferred Revenue Distributor Transactions DeferredRevenueDistributorTransactions	3735000	USD
CY2013Q1	mxl	Deferred Revenue Distributor Transactions DeferredRevenueDistributorTransactions	4948000	USD
CY2013Q1	mxl	Deferred Revenue Rebates DeferredRevenueRebates	15000	USD
CY2012Q4	mxl	Deferred Revenue Rebates DeferredRevenueRebates	23000	USD
CY2013Q1	mxl	Increase Decrease In Accrued Price Protection Liabilities IncreaseDecreaseInAccruedPriceProtectionLiabilities	1908000	USD
CY2012Q1	mxl	Increase Decrease In Accrued Price Protection Liabilities IncreaseDecreaseInAccruedPriceProtectionLiabilities	527000	USD
CY2013Q1	mxl	Number Of Class Of Stock Outstanding NumberOfClassOfStockOutstanding	2	class
CY2012Q3	mxl	Number Of Patents In Connection With Patent Infringement Matters NumberOfPatentsInConnectionWithPatentInfringementMatters	3	patent
CY2012Q3	mxl	Number Of Patents In Connection With Patent Infringement Matters NumberOfPatentsInConnectionWithPatentInfringementMatters	19	patent
CY2013Q1	mxl	Number Of Patents In Connection With Patent Infringement Matters NumberOfPatentsInConnectionWithPatentInfringementMatters	19	patent
CY2013Q1	mxl	Number Of Patents In Connection With Patent Infringement Matters Additiona NumberOfPatentsInConnectionWithPatentInfringementMattersAdditiona	1	patent
CY2013Q1	mxl	Number Of Patents In Connection With Patent Infringement Matterscounterclaims NumberOfPatentsInConnectionWithPatentInfringementMatterscounterclaims	5	patent
CY2013Q1	mxl	Percentage Of Revenue From Companys Distributors PercentageOfRevenueFromCompanysDistributors	0.28
CY2012Q1	mxl	Percentage Of Revenue From Companys Distributors PercentageOfRevenueFromCompanysDistributors	0.49
CY2013Q1	mxl	Period Of Change Of Unrecognized Tax Benefits PeriodOfChangeOfUnrecognizedTaxBenefits	P12M
CY2013Q1	mxl	Share Based Compensation Arrangement By Share Based Payment Award Award Expiration Period Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriodMaximum	P10Y
CY2013Q1	mxl	Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodMinimum	P7Y
CY2013Q1	mxl	Share Based Payment Award Options Exercise Price As Percentage Of Common Stock Fair Value Minimum ShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfCommonStockFairValueMinimum	1
CY2013Q1	mxl	Taxable Income Adjustment From Tax Examination TaxableIncomeAdjustmentFromTaxExamination	0	USD
CY2013Q1	mxl	Term Of Invoice Of Distributor TermOfInvoiceOfDistributor	P30D
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001288469
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	MAXLINEAR INC
CY2013Q1	dei	Trading Symbol TradingSymbol	MXL

Files In Submission

Name	View Source	Status
0001445305-13-001002-index-headers.html	Edgar Link	pending
0001445305-13-001002-index.html	Edgar Link	pending
0001445305-13-001002.txt	Edgar Link	pending
0001445305-13-001002-xbrl.zip	Edgar Link	pending
ex1012formofchangeincontro.htm	Edgar Link	pending
ex1013formofchangeincontro.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
mxl-20130331.xml	Edgar Link	completed
mxl-20130331.xsd	Edgar Link	pending
mxl-20130331_cal.xml	Edgar Link	unprocessable
mxl-20130331_def.xml	Edgar Link	unprocessable
mxl-20130331_lab.xml	Edgar Link	unprocessable
mxl-20130331_pre.xml	Edgar Link	unprocessable
mxl-2013331x10q.htm	Edgar Link	pending
mxl-2013331xex311.htm	Edgar Link	pending
mxl-2013331xex312.htm	Edgar Link	pending
mxl-2013331xex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MXL
MAXLINEAR, INC Stock $mxl

2013 Q1 Form 10-Q Financial Statement

#000144530513001002 Filed on May 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MXL MAXLINEAR, INC Stock $mxl

2013 Q1 Form 10-Q Financial Statement

#000144530513001002 Filed on May 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MXL
MAXLINEAR, INC Stock $mxl